TRVI
Trevi Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+0.05%
vs ±14.8% implied · ×0.00
shaded = implied · ▲▼ = realized
No thesis.
Largest filed tie
—
Trevi Therapeutics, Inc.
13.50
−0.06 · −0.44%
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | NEA ManagementNEA | $246.6M | 8.79% | 0.00% | |
| 2 | FMRFMR | $234.3M | 8.35% | +56.29% | |
| 3 | BlackRockBlackRockindex-like | $208.0M | 7.42% | +8.93% | |
| 4 | Frazier Life Sciences ManagementFrazier Life Sciences | $185.4M | 6.61% | 0.00% | |
| 5 | Wellington Management GroupWellington | $106.0M | 3.78% | +9.55% | |
| 6 | Vanguard Capital ManagementVanguardindex-like | $103.1M | 3.68% | +11.09% | |
| 7 | Vivo CapitalVivo Capital | $95.0M | 3.39% | 0.00% | |
| 8 | Woodline PartnersWoodline Partners | $76.1M | 2.71% | +307.81% | |
| 9 | Vestal Point CapitalVestal Point Capital | $57.8M | 2.06% | +43.09% | |
| 10 | MPM Oncology Impact ManagementMPM Oncology Impact | $57.3M | 2.04% | −6.82% | |
| 11 | Frontier Capital ManagementFrontier | $57.3M | 2.04% | +53.98% | |
| 12 | State StreetState Streetindex-like | $56.5M | 2.01% | +13.58% | |
| 13 | Geode Capital ManagementGeodeindex-like | $54.6M | 1.95% | +5.39% | |
| 14 | Marshall WaceMarshall Wace | $49.9M | 1.78% | −32.57% | |
| 15 | Eventide Asset ManagementEventide | $49.6M | 1.77% | +1.44% | |
| 16 | Rubric Capital ManagementRubric | $46.7M | 1.67% | −32.54% | |
| 17 | AlliancebernsteinAlliancebernstein | $43.9M | 1.57% | −17.22% | |
| 18 | Artia Global PartnersArtia Global Partners | $41.2M | 1.47% | +9.80% | |
| 19 | Acorn Capital AdvisorsAcorn Capital | $40.0M | 1.43% | 0.00% | |
| 20 | First Light Asset ManagementFirst Light | $39.1M | 1.39% | new | |
| 21 | Pictet Asset Management HoldingPictet | $37.6M | 1.34% | +18.04% | |
| 22 | Logos Global ManagementLogos Global | $35.1M | 1.25% | −21.67% | |
| 23 | Affinity Asset AdvisorsAffinity Asset | $33.6M | 1.20% | −10.00% | |
| 24 | Emerald AdvisersEmerald | $33.5M | 1.20% | −2.28% | |
| 25 | SirenSiren | $33.3M | 1.19% | 0.00% |
219 managers report $2.8B of Trevi Therapeutics on form 13F for the quarter ended Jun 30 '26. 33 of them hold 80% of it; NEA is largest at 8.79%.
Expected move
Inputsspot 13.56exp Nov 20ATM strike 14ATM straddle 3.28IV 124%